Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
about
Corticosteroids as adjunctive therapy in the treatment of influenzaSevere community-acquired pneumonia: timely management measures in the first 24 hoursProlonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired WeaknessArgument against the Routine Use of Steroids for Pediatric Acute Respiratory Distress SyndromeCorticosteroids in the adjunctive therapy of community-acquired pneumonia: an appraisal of recent meta-analyses of clinical trialsAdjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-AnalysisThe Role of Open Lung Biopsy in Critically Ill Patients with Hypoxic Respiratory Failure: A Retrospective Cohort Study.Epidemiology, virulence factors and management of the pneumococcusNew aspects in the management of pneumoniaProlonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature.TNF Drives Monocyte Dysfunction with Age and Results in Impaired Anti-pneumococcal Immunity.PURLs: This adjunct medication can speed CAP recoveryEfficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis.Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.A Case of Long-Term Seronegative Human Immunodeficiency Virus (HIV) Infection: The Importance of the Humoral Response to HIVSevere Community-Acquired Pneumonia Caused by Human Adenovirus in Immunocompetent Adults: A Multicenter Case Series.Different characteristics associated with intensive care unit transfer from the medical ward between patients with acute exacerbations of chronic obstructive pulmonary disease with and without pneumoniaCommunity-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.Inflammasome Activation Can Mediate Tissue-Specific Pathogenesis or Protection in Staphylococcus aureus Infection.Effect of Oral Prednisolone on Symptom Duration and Severity in Nonasthmatic Adults With Acute Lower Respiratory Tract Infection: A Randomized Clinical Trial.Management of inflammatory bowel disease with Clostridium difficile infection.Precision medicine for the treatment of severe pneumonia in intensive care.Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review.Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?Adjuvants to mechanical ventilation for acute respiratory distress syndrome.Preadmission Oral Corticosteroids Are Associated With Reduced Risk of Acute Respiratory Distress Syndrome in Critically Ill Adults With Sepsis.Clinical Management of Community Acquired Pneumonia in the Elderly Patient.Benefit of adjunct corticosteroids for community-acquired pneumonia in diabetic patients.South African guideline for the management of community-acquired pneumonia in adults.Adjuvant corticosteroids for patients hospitalized with community-acquired pneumonia: is it time?Inhalation therapies in acute respiratory distress syndrome.Caution! Overestimation of treatment effects of corticosteroid therapy for community-acquired pneumonia in a meta-analysis of randomized controlled trials.Antibiotic therapy, supportive treatment and management of immunomodulation-inflammation response in community acquired pneumonia: review of recommendationsSystemic corticosteroids and community-acquired pneumonia-cautious optimism or wishful thinking?Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome.Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.Corticosteroids for pneumonia.Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017.Adjuvant therapies in critical care: steroids in community-acquired pneumonia.Adjuvant therapies in critical care: steroids to treat infectious diseases.
P2860
Q24186045-20D6876D-57A6-46FD-9575-7CB6B53A2E60Q26738591-F1EDC10F-41EC-45F0-BE73-8DED557DC01BQ26741099-D5F7D5ED-5617-4052-88AA-85FFFB647258Q26741709-0F754726-0638-4162-BFCF-6B89A70EE214Q26748532-158014AB-F792-4619-87E0-D935EAB15F2EQ26774000-B5DBF37F-E802-43C7-AAFB-1E5828206934Q27349283-B6CCE6DB-D6DD-4F56-9890-9FECC820564EQ28078832-9E07C859-9048-4976-B902-A63A7989A2AAQ28080025-2E5DB495-2076-4649-A097-0E463A56C82CQ35823842-6B48E7AC-E4C0-43F6-B1E9-1CE622F1C348Q35894071-61ADEBD2-ED53-46D9-B11B-D2321791E582Q36180825-8A2C21B9-570A-4A86-A0CE-1FA2C2BA1194Q36192686-23447D0D-BD1A-4CA4-B1B8-A601EBA7A2CAQ36406243-02A1D8E1-DCB1-422F-8816-EE721CD884DCQ36548103-6B7CF7D9-E34A-4308-BCC5-40BEC529E5FFQ36677639-92B8E03B-AE6C-47FC-9262-02B1E7FE405EQ36948992-97573F54-7D04-4E08-B956-796811EAE418Q37175317-8C716007-FB28-4C74-9FA3-EFFC6EC2FCF1Q37486275-4550E912-604A-47BA-B1E7-7A7E370CF8C7Q38371827-1EEBCC03-CE5A-4F31-B668-06D27EF9F311Q38635974-658685F4-95CD-4705-83C8-C373119C12E8Q38704065-CA9F53EB-8AE3-4A47-A51B-F73276103FF1Q38740312-94F55D51-57EC-43CF-99F8-418530792EECQ38775825-2B067D2E-40D1-4941-8A7E-D43A2A15365DQ38792121-483F5D0E-1AAD-4867-8AB1-AC6065EDBEDBQ38931019-D9259ECE-B064-46C8-8537-7234AD7B9787Q38969066-626F6C88-2D07-4556-A37E-D619EA72127FQ39403807-4F6433E0-3504-41E0-8E41-D0D02538B248Q39455917-B61E81A4-3A63-45A3-8B9F-8200DFD87D46Q40555088-1233E5A6-98D5-46CE-8987-434D45AB1081Q41190745-478703D9-ED0C-4AE8-8460-E1F5E8425FA0Q42079575-3147E13F-E9D6-41F5-ABF5-5D33149EB4A9Q42370479-7C58BA2D-29BF-49A1-91A4-EC960A1B6E0AQ43102393-CDCB65DA-A2BD-4809-BC7E-A5305633C4F9Q44663643-B22AC8AD-A60F-4EE0-9267-12987EAD2AADQ47096485-EDDA5589-F512-4A59-8615-8646EDDFE383Q47317972-264A4B31-5BB2-4977-83AE-A98FC000E283Q47627293-48820AC5-F434-49B2-9425-15AB0A06CBF4Q47731925-0EC8AD96-04D6-49E7-B7F5-DE360A35B0E7Q49914898-FCAF69D3-3F73-4EE9-903C-90148017C3DF
P2860
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@ast
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@en
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@en-gb
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@nl
type
label
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@ast
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@en
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@en-gb
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@nl
altLabel
Corticosteroid Therapy for Pat ...... matic Review and Meta-analysis
@en
prefLabel
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@ast
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@en
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@en-gb
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@nl
P2093
P50
P921
P3181
P356
P1476
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
@en
P2093
Gordon H. Guyatt
Manya Prasad
Maureen O. Meade
Nathan Evaniew
Paul E. Alexander
Reed A.C. Siemieniuk
Yutong Fei
P3181
P356
10.7326/M15-0715
P407
P577
2015-10-06T00:00:00Z